[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Live Cell Imaging Market Outlook 2020

July 2015 | 60 pages | ID: G507B131BBCEN
RNCOS E-Services Pvt. Ltd.

US$ 1,400.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The new report introduced by RNCOS entitled, “Global Live Cell Imaging Market Outlook 2020”, includes a comprehensive analysis of the current and future outlooks of the live cell imaging industry. The report presents a detailed description of several techniques involved in imaging of living cells, as well as the segmentation of the market by products, applications and geography. As per RNCOS’ analysis, live cell imaging is widely penetrating in a number of fields such as cell biology, developmental biology, neurobiology and electrophysiology. It is emerging as a powerful tool for providing critical insights into cell function, including dynamic processes in living cells with nano-scale resolution in real time. Recent advances in microscopy techniques such as fluorescence light microscopy, including super resolution, photo activation, etc. are enriching live cell imaging for a number of applications.

Live Cell Imaging is growing in both developed and developing nations. It has been noted that a multitude of countries are significantly investing in LCI research. Other factors such as increasing development and availability of fluorescent protein and dye technologies, the growing interest of public and private sectors and increasing automation will drive the industry to grow with CAGR of 8% in the next six years (2014-2020). However, technical difficulties like maintaining live cells on the microscope stage and the shortage of skilled professionals are likely to be the major roadblocks for the industry.

Currently, the live cell imaging market is dominated by cell biology applications. Researchers are effectively exploiting the specialty of the technology in specifying the structural components and the spatial heterogeneity of a normal cell. The report also illustrates the competitive landscape influencing the current industry situation. Both established players as well as start-ups are using different business strategies to sustain in the market. Most commonly used strategies used by the players are new product launches and mergers & collaborations. Some of the key players in the market include Carl Zeiss, Nikon Instruments, Leica Microsystems, PerkinElmer, Thermo Fisher Scientific, among others. The study also incorporates a SWOT analysis of key players and developments occurring at the player level since the last two years.
1. ANALYST VIEW

2. RESEARCH METHODOLOGY

3. LIVE CELL IMAGING- AN INTRODUCTION

4. LIVE CELL IMAGING MARKET OVERVIEW

5. DRIVERS & CHALLENGES

5.1 Drivers
  5.1.1 Rising Incidence of Chronic Diseases
  5.1.2 Surging Demand of High-Content Screening Techniques
  5.1.3 Increasing Funding Support by Public and Private Sector
5.2 Challenges
  5.2.1 Maintaining Live Cells on Microscope Stage
  5.2.2 Lack of Awareness
  5.2.3 Shortage of Skilled Professionals

6. MARKET SEGMENTATION

6.1 By Products
6.2 By Applications
6.3 By Geography

7. TRENDS & DEVELOPMENTS

7.1 Fluorescent Probes Enriching Live Cell Imaging
7.2 Live Cell Imaging Revealing Intracellular Interactions
7.3 Introduction of Single Plane Illumination Microscopy Advancing Live Cell Imaging

8. MERGERS & OTHER COLLABORATIONS

9. COMPETITIVE ASSESSMENT

9.1 Carl Zeiss GmbH
9.2 Becton Dickenson
9.3 Olympus Corporation
9.4 Thermo Fisher Scientific
9.5 Sigma-Aldrich
9.6 Perkin Elmer
9.7 Nikon Instruments
9.8 GE Healthcare
9.9 Leica Microsystems

LIST OF FIGURES:

Figure 4-1: Global - Live Cell Imaging Market (Billion US$), 2014-2020
Figure 6-1: Global - Live Cell Imaging Market by Products (%), 2014
Figure 6-2: Global - Live Cell Imaging Market by Applications (%), 2014
Figure 6-3: Global - Live Cell Imaging Market by Geography (%), 2014
Figure 9-1: Carl Zeiss - Revenue Breakup by Geography (%), 2014
Figure 9-2: Becton Dickenson - Revenue Breakup by Geography (%), 2014
Figure 9-3: Olympus Co - Revenue Breakup of Lifesciences Business by Geography (%), 2014
Figure 9-4: Thermo Fisher Scientific - Revenue Breakup by Geography (%), 2014
Figure 9-5: Sigma - Revenue Breakup by Geography (%), 2014
Figure 9-6: Perkin Elmer - Revenue Breakup by Geography (%), 2014
Figure 9-7: Nikon Instruments - Revenue Breakup by Geography (%), 2014
Figure 9-8: GE Healthcare - Breakup of Revenue by Business Segments (%), 2014
Figure 9-9: GE Healthcare - Breakup of Revenue by Geographies (%), 2014

LIST OF TABLES:

Table 5-1: Funds Announced for Live Cell Imaging Research (2013-2015)
Table 9-1: Carl Zeiss - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-2: Becton Dickenson - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-3: Olympus Co - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-4: Thermo Fisher Scientific - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-5: Sigma - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-6: Perkin Elmer - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-7: Nikon Instruments - Revenue by Business Segments (Million US$), 2013 & 2014


More Publications